Standout Papers

Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A ... 1988 2026 2000 2013 16.5k
  1. Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach (1988)
    Elizabeth R. DeLong, David M. DeLong et al. Biometrics
  2. Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer (1996)
    William P. McGuire, William J. Hoskins et al. New England Journal of Medicine
  3. Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer (1999)
    Peter G. Rose, Brian N. Bundy et al. New England Journal of Medicine
  4. Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study (2003)
    Robert F. Ozols, Brian N. Bundy et al. Journal of Clinical Oncology
  5. Randomized Comparison of Fluorouracil Plus Cisplatin Versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIB-IVA Carcinoma of the Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study (1999)
    Charles W. Whitney, William T. Sause et al. Journal of Clinical Oncology
  6. Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer (1996)
    David S. Alberts, P. Y. Liu et al. New England Journal of Medicine
  7. American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer (2007)
    Gary H. Lyman, Alok A. Khorana et al. Journal of Clinical Oncology
  8. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. (1990)
    Andrew Berchuck, Ayman H. Kamel et al. PubMed

Immediate Impact

3 by Nobel laureates 4 from Science/Nature 103 standout
Sub-graph 1 of 18

Citing Papers

Biologically informed deep neural network for prostate cancer discovery
2021 StandoutNature
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
2021 Standout

Works of Daniel L. Clarke‐Pearson being referenced

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
2003 Standout
Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach
1988 Standout

Author Peers

Author Last Decade Papers Cites
Daniel L. Clarke‐Pearson 9284 8191 9668 210 35.1k
Patrick M. Bossuyt 4700 4165 13198 749 59.4k
Valerie Beral 3213 2507 2598 340 32.3k
Hein Putter 1674 2774 11998 692 37.1k
Patrick Maisonneuve 2755 2999 11821 555 40.6k
Malcolm C. Pike 3098 1769 3564 402 32.6k
Paul Meier 1427 1395 9707 78 42.6k
Mahesh Parmar 2388 1197 6455 284 26.1k
Edward L. Kaplan 1420 1218 10184 229 53.5k
­Eero Pukkala 2192 1514 6911 724 37.9k
Val Gebski 2056 1995 6642 462 19.6k

All Works

Loading papers...

Rankless by CCL
2026